EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

NCT00129935 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1384

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Capecitabine
DRUG: Epirubicin
DRUG: Cyclophosphamide

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]
[object Object]
[object Object]